News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders
Photo taken from Marlene Thomas/LinkedIn
Mar 3, 2024, 17:30

Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders

Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn:

“I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders through this year’s program. This open dialogue is instrumental in breaking down barriers and fostering cross-sector collaborations, which can help to accelerate R&D and translate innovation into healthcare systems.

I had the pleasure to co-lead an educational session on ctDNA applications with Umberto Malapelle, Sandi Deans, Anastasios Stathis, and Daniel Shao Weng Tan.

Through liquid biopsy, we are transitioning from detecting individual mutations to gaining a holistic understanding of the disease and with this inform personalised treatment strategies.”

Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders

Source: Marlene Thomas/LinkedIn

Anastasios Stathis cancer clinical care collaborative discussions ctDNA Daniel Shao Weng Tan ESMO ESMO TAT 2024 European Society for Medical Oncology liquid biopsy Marlene Thomas OncoDaily Oncology Precision Medicine Roche Sandi Deans Targeted Anticancer Therapies Umberto Malapelle
Special Coverage
Science
Mar 22, 2025, 09:11
Myeloma Paper of the Day, March 22nd, suggested by Robert Orlowski
Blog
Mar 22, 2025, 09:00
Andrea Anampa-Guzmán: Fantastic time at the ASCO AIOM Clinical Research Course
Blog
Mar 22, 2025, 08:43
Richard Sassun: It is time to give Tumor Deposit a proper role in the staging
Blog
Mar 22, 2025, 08:34
Registration open for the 8th "Combinations and Sequences in therapy" conference
Blog
Mar 22, 2025, 08:02
AstraZeneca announced plans to establish a new global strategic Research and Development center in Beijing
Science
Mar 22, 2025, 07:56
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma Tumors - The Babak Lab
Blog
Mar 22, 2025, 07:49
UICC joined the Commonwealth Secretariat and the Lancet Oncology Commission in London
Blog
Mar 22, 2025, 07:42
President of Cairo University visited the Breast Cancer Hospital (NCI - New Cairo)
Blog
Mar 22, 2025, 07:31
Istvan Petak: We have officially launched BRECISE in Madrid
Science
Mar 22, 2025, 07:26
Elvina Almuradova: Cemiplimab monotherapy vs chemotherapy as a first-line treatment with advanced NSCLC with PD-L1 expression
Blog
Mar 22, 2025, 07:23
Reducing disparities in cancer prevention, screening, and access to treatment - SPCC
Science
Mar 22, 2025, 07:12
Jennifer Bires: Fertility Preservation in People with Cancer